Life-Changing Science

Driven to transform the lives of patients
through a new generation of RNA therapeutics

About Us

Latest Announcements

RP11 Clinical Trial Progressing To High Dose Cohort 18/12/2023

RP11 Clinical Trial Progressing To High Dose Cohort 18/12/2023

Read More arrow_Icon
Response to Price Query 30/11/2023

Response to Price Query 30/11/2023

Read More arrow_Icon
Supplementary Information 16/11/2023

Supplementary Information 16/11/2023

Read More arrow_Icon

We discover and develop RNA therapies to change the lives of patients with genetic diseases

PYC Therapeutics combines world-leading RNA therapeutic drug design with a revolutionary delivery technology based on a proprietary library of naturally derived Cell Penetrating Peptides (CPPs) to solve the delivery challenge associated with traditional RNA therapeutics.

disease-areas-3

Disease areas

PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications

View Our Disease Areas arrow_Icon
the-future-of-our-science-2

The future of
our science

Our Platform is highly versatile and modular, offering broad potential across therapeutic areas.

Our Science arrow_Icon
life-changing-science-2

Life-Changing Science

PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. Truly Life-Changing Science.

Patient Trials arrow_Icon
Group 1

Stay Connected

Subscribe to our mailing list: